Equities

Monash IVF Group Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Monash IVF Group Ltd

Actions
  • Price (EUR)0.40
  • Today's Change-0.006 / -1.48%
  • Shares traded108.00
  • 1 Year change-43.26%
  • Beta0.7343
Data delayed at least 15 minutes, as of Mar 02 2026 13:58 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Monash IVF Group Limited is a provider of Assisted Reproductive Services (ARS). It offers a range of techniques used to assist patients experiencing infertility in achieving a clinical pregnancy, including reproductive genetic services. It is also a provider of specialized women's imaging services. It provides a range of specialist diagnostic obstetric and gynecological ultrasound and fertility treatment. Its segments consist of two operations: Australia IVF and Ultrasound, providing ARS, ultrasound and other related services. International IVF, providing ARS in Southeast Asia. Its business includes fertility solutions that provide fertility treatment and care; KL Fertility is a fertility specialist center; Monash IVF is a fertility research and treatment center; Monash IVF KPJ Johor is a full-service hospital-based fertility center, and Monash Ultrasound for Women provides tertiary level prenatal diagnostic services. Its business also includes Repromed and Sydney Ultrasound for Women.

  • Revenue in AUD (TTM)269.47m
  • Net income in AUD15.16m
  • Incorporated2014
  • Employees892.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.